[Effect of Increasing Tidewater Inundation on Porewater Geochemistries and CO2 and CH4 Effluxes in the Tidal Freshwater Marshes of the Minjiang River Estuary, Southeast China].

While the effect of increasing tidewater inundation caused by sea-level rise on carbon cycling had been well studied in saltmarshes, little is known about the effect of increasing tidewater inundation on CO2 and CH4 effluxes in the tidal freshwater marsh soils. Herein, the effects of tide inundation on porewater geochemistries (NH4+, NO3-, DOC, dissolved CH4, and DIC) and CH4 and CO2 effluxes were examined in the soils of tidal freshwater marshes in the Minjiang River Estuary, East China Sea. By applying "mesocosm" and a simulated tide pool, the tide inundation height increased by 15 cm and 30 cm over the control (CK). The CO2 effluxes decreased by 28.53% and 36.56%, and the dissolved CH4 concentrations increased by 47.83% and 73.91%, in treatments (CK+15 cm) and (CK+30 cm), respectively. The CH4 effluxes did not change significantly in the treatment (CK+15 cm), but increased by 29.27% in treatment (CK+30 cm). The increasing tidewater inundation had no significant impact on DOC concentrations, but increased NH4+ concentrations and decreased DIC and NO3- concentrations. Increasing tide inundation also reduced the temperature sensitivity of CH4 and CO2 effluxes. The study highlighted that the sea level rise-induced increase in tidewater inundation would decrease the annual global warming potential of tidal freshwater wetlands by 28% and 35% in the next 50 and 100 years, respectively.

[Parallel Factor Analysis of Fluorescence Excitation Emission Matrix Spectroscopy of CDOM from the Mid-culture Period of Shrimp Ponds in a Subtropical Estuary].

Components of chromophoric dissolved organic matter (CDOM) from eight coastal land-based shrimp ponds in the Minjiang, Mulan, and Jiulong rivers of subtropical southeastern China were determined by fluorescence excitation emission matrix spectroscopy combined with parallel factor analysis (EEMs-PARAFAC). Four separate fluorescence components, including two protein-like components (C1, C4) and two humic-like components (C2, C3), were identified as the dominant components of the CDOM in these shrimp ponds. The fluorescence indices (FI, BIX, and HIX) suggest that the CDOM of shrimp ponds shows low humification and is mainly derived from spontaneous sources. The protein-like and humic-like components have similar sources and exhibit a similar geochemical behavior. The salinity is negatively correlated with all CDOM fractions, whereas the DOC concentrations show only a positive correlation with the humic fractions of the CDOM. This study provides a scientific basis for the photochemical properties of CDOM in shrimp ponds.

An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis.

Runt-related transcription factor 3 (RUNX3) methylation plays an important role in the carcinogenesis of breast cancer (BC). However, the association between RUNX3 hypermethylation and significance of BC remains under investigation. The purpose of this study is to perform a meta-analysis and literature review to evaluate the clinicopathological significance of RUNX3 hypermethylation in BC. A comprehensive literature search was performed in Medline, Web of Science, EMBASE, Cochrane Library Database, CNKI and Google scholar. A total of 10 studies and 747 patients were included for the meta-analysis. Pooled odds ratios (ORs) with corresponding confidence intervals (CIs) were evaluated and summarized respectively. RUNX3 hypermethylation was significantly correlated with the risk of ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC), OR was 50.37, p < 0.00001 and 22.66, p < 0.00001 respectively. Interestingly, the frequency of RUNX3 hypermethylation increased in estrogen receptor (ER) positive BC, OR was 12.12, p = 0.005. High RUNX3 mRNA expression was strongly associated with better relapse-free survival (RFS) in BC patients. In summary, RUNX3 methylation could be a promising early biomarker for the diagnosis of BC. High RUNX3 mRNA expression is correlated to better RFS in BC patients. RUNX3 could be a potential therapeutic target for the development of personalized therapy.